View clinical trials related to Colonic Neoplasms.
Filter by:This clinical trial will be conducted as a single-center, open-label, Phase I/2 trial to evaluate the feasibility and safety of Yttrium-90 radioembolization (Y90-RE) in combination with a fixed dose of of immunotherapy (durvalumab - 750 mg) in subjects with liver-predominant, metastatic colorectal cancer (mCRC), which is mismatch repair proficient/microsatellite stable (pMMR/MSS).
The main aim of the present study is to test the efficacy and safety of CITOGENEX administration in patients with colon-rectal cancer.